Quest Diagnostics Data License (CSELS) Cost Share

The contract pertains to an annual data submission related to drug testing under the identifier 75D30122C13345/200-2022-13345, specifically option 3, managed by the Partnerships and Evaluation Branch within the Centers for Disease Control and Prevention. The agreement involves Quest Diagnostics Incorporated and focuses on a data license service known as CSELS, which appears to involve cost sharing. While certain contract details such as solicitation number, NAICS code, and specific place of performance are not provided, the contract is forecasted and related to data management and evaluation activities critical to drug testing programs. Key contacts for this contract include Charla Jackson, who serves as the program point of contact, and a contracting officer whose identity is yet to be determined. The contract emphasizes collaboration between CDC and Quest Diagnostics to facilitate reliable data submission and sharing to support drug test-related public health evaluations. Overall, the contract represents an ongoing partnership aimed at ensuring data integrity and analysis to inform drug use monitoring and public health strategies.